The closing price of Tenaya Therapeutics Inc (NASDAQ: TNYA) was $5.52 for the day, down -13.75% from the previous closing price of $6.40. In other words, the price has decreased by -$0.88 from its previous closing price. On the day, 678759 shares were traded.
Ratios:
Our analysis of TNYA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.55 and its Current Ratio is at 6.55. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on November 30, 2023, initiated with a Outperform rating and assigned the stock a target price of $7.
On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 05 ’24 when Hoey Timothy sold 3,300 shares for $7.00 per share. The transaction valued at 23,101 led to the insider holds 245,346 shares of the business.
Hoey Timothy sold 6,569 shares of TNYA for $35,046 on Feb 20 ’24. The Chief Scientific Officer now owns 236,146 shares after completing the transaction at $5.34 per share. On Feb 16 ’24, another insider, Tingley Whittemore, who serves as the Chief Medical Officer of the company, sold 6,500 shares for $5.86 each. As a result, the insider received 38,090 and left with 73,534 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNYA now has a Market Capitalization of 492.80M and an Enterprise Value of 383.09M.
Stock Price History:
Over the past 52 weeks, TNYA has reached a high of $8.09, while it has fallen to a 52-week low of $1.66. The 50-Day Moving Average of the stock is 4.64, while the 200-Day Moving Average is calculated to be 4.02.
Shares Statistics:
TNYA traded an average of 576.86K shares per day over the past three months and 639.34k shares per day over the past ten days. A total of 66.86M shares are outstanding, with a floating share count of 60.72M. Insiders hold about 21.14% of the company’s shares, while institutions hold 46.60% stake in the company. Shares short for TNYA as of Feb 15, 2024 were 2.48M with a Short Ratio of 4.30, compared to 2.35M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.22% and a Short% of Float of 4.48%.
Earnings Estimates
The firm’s stock currently is rated by 8 analysts. On average, analysts expect EPS of -$0.44 for the current quarter, with a high estimate of -$0.4 and a low estimate of -$0.5, while EPS last year was -$0.61. The consensus estimate for the next quarter is -$0.43, with high estimates of -$0.41 and low estimates of -$0.47.
Analysts are recommending an EPS of between -$1.68 and -$1.8 for the fiscal current year, implying an average EPS of -$1.73. EPS for the following year is -$1.67, with 7 analysts recommending between -$1.1 and -$1.99.
